IL PORTALE per la RICERCA dei DIPARTIMENTI

F. Porpiglia (2011) "A debate on laparoscopic versus open adrenalectomy for adrenocortical carcinoma."

Scagliotti GV (2011) "A double-blind, randomised, placebo-controlled phase III intergroup study of gefitinib in patients with advanced NSCLC, non-progressing after first line platinum-based chemotherapy (EORTC 08021/ILCP 01/03)."

Scagliotti GV, Ricardi U (2011) "A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin-docetaxel, plus radical concurrent chemoradiotherapy with cisplatin-docetaxel, in patients with unresectable locally advanced non-small-cell lung cancer."

Medico E (2011) "Anaplastic large-cell lymphoma"

Medico E (2011) "Anaplastic lymphoma kinase in human cancer"

Ricardi U (2011) "Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)."

F. Porpiglia (2011) "Contemporary management of adrenocortical carcinoma."

Bardelli A (2011) "Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjects."

Ragona R (2011) "Distinct Effects of Leukocyte and Cardiac Phosphoinositide 3-Kinase {gamma} Activity in Pressure Overload-Induced Cardiac Failure"

Cagnoni G. (2011) "Dysregulation of Semaphorin7A/{beta}1-integrin signaling leads to defective GnRH-1 cell migration, abnormal gonadal development and altered fertility."

Ghigo D, Bergandi L (2011) "Effects of TiO2-containing phosphate glasses on solubility and in vitro biocompatibility"

Rehman M (2011) "Eisosome-driven plasma membrane organization is mediated by BAR domains RID C-3043-2008"

Corso S, Giordano S, Aglietta M (2011) "Enhanced c-Met activity promotes G-CSF induced mobilization of hematopoietic progenitor cells via ROS signaling."

Ferru E (2011) "Erythrocyte membrane changes of chorea-acanthocytosis are the result of altered Lyn kinase activity."

Giordano S (2011) "Expression of c-jun is not mandatory for mouse hepatocyte proliferation induced by two nuclear receptor ligands: TCPOBOP and T3"

Ricardi U (2011) "First-Line Treatment for Primary Testicular Diffuse Large B-Cell Lymphoma With Rituximab-CHOP, CNS Prophylaxis, and Contralateral Testis Irradiation: Final Results of an International Phase II Trial."

Smith IE (2011) "First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2,251 patients."

Francesco Galimi, Claudio Isella, Davide Corà, Enzo Medico, M.F. Di Renzo, Paolo M. Comoglio, Livio Trusolino*, Andrea Bertotti* (*Co-Senior Authors) (2011) "Genetic and expression analysis of MET, MACC1 and HGF in metastatic colorectal cancer: Response to Met inhibition in patient xenografts and pathological correlations"

Medico E (2011) "Human neurotrophin receptor p75NTR defines differentiation-oriented skeletal muscle precursor cells: implications for muscle regeneration"

Di Nicolantonio F, Bardelli A (2011) "Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancer"

Medico E, Comoglio PM, Boccaccio C (2011) "Induction of MET by Ionizing Radiation and Its Role in Radioresistance and Invasive Growth of Cancer"

Aglietta M, Tampellini M (2011) "International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the fourth symposium on primary systemic therapy in the management of operable breast cancer, cremona, Italy (2010)"

Ricardi U., Filippi A.R. (2011) "Interobserver variability of clinical target volume delineation in supra-diaphragmatic Hodgkin's disease: a multi-institutional experience"

Gazzano E, Aldieri E, Ghigo D (2011) "Nitric oxide stimulates human sperm motility via activation of the cyclic GMP/protein kinase G signaling pathway"

Aglietta M (2011) "No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients"

Duregon E, Volante M, Papotti M. (2011) "Oncocytic Adrenocortical Tumors: Diagnostic Algorithm and Mitochondrial DNA Profile in 27 Cases."

Scagliotti GV (2011) "Paradigm shifts in lung cancer as defined in the new IASLC/ATS/ERS lung adenocarcinoma classification."

Gandolfo S (2011) "Periodontal status in oral mucous membrane pemphigoid: initial results of a case-control study"

Novello S, Scagliotti G. (2011) "Phase II Study of Sunitinib in Patients with Non-small Cell Lung Cancer and Irradiated Brain Metastases."

Volante M, Papotti M (2011) "Phase II study of weekly paclitaxel and sorafenib as second/third line therapy in patients with adrenocortical carcinoma."

Novello S (2011) "Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab. "

Tampellini M (2011) "Prediction of Survival by Neutropenia According To Delivery Schedule of Oxaliplatin-5-Fluorouracil-Leucovorin for Metastatic Colorectal Cancer in a Randomized International Trial (EORTC 05963)."

Primo L, Bussolino F (2011) "Priming of the vascularendothelial growth factor signaling pathway by thrombospondin-1, CD36, and spleentyrosine kinase"

Novello S, Scagliotti GV (2011) "Pulmonary toxicity related to systemic treatment of nonsmall cell lung cancer."

Scagliotti G. (2011) "Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non-Small-Cell Lung Cancer."

Novello S (2011) "Randomized phase II study of erlotinib in combination with placebo or R1507, a monoclonal antibody to insulin-like growth factor-1 receptor, for advanced-stage non-small-cell lung cancer."

Scagliotti GV (2011) "Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma."

Scagliotti GV, Papotti M (2011) "Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer."

Ferru E, Turrini F (2011) "Regulation of membrane-cytoskeletal interactions by tyrosine phosphorylation of erythrocyte band 3."

Tamagnone L (2011) "Sema4C-Plexin B2 signalling modulates ureteric branching in developing kidney"

Tamagnone L (2011) "Semaphorin signals on the road of endothelial tip cells."

Bussolino F, Lanzetti L. (2011) "Small GTPase Rab5 participates in chromosome congression and regulates localization of the centromere-associated protein CENP-F to kinetochores."

Novello S. (2011) "Strategies for prolonged therapy in patients with advanced non-small-cell lung cancer."

Capparuccia L, Tamagnone L (2011) "Systemic and Targeted Delivery of Semaphorin 3A Inhibits Tumor Angiogenesis and Progression in Mouse Tumor Models"

S. Doublier (2011) "Testosterone and 17ß-estradiol have opposite effects on podocyte apoptosis that precedes glomerulosclerosis in female estrogen receptor knockout mice"

Giorgio Saracco (2011) "The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study"

Papotti M, Duregon E, Volante M (2011) "The weiss score and beyond--histopathology for adrenocortical carcinoma."

Di Nicolantonio F, Bardelli A (2011) "Toll-like receptor 9 agonist IMO cooperates with cetuximab in K-ras mutant colorectal and pancreatic cancers"

Leuci V, Capellero S, Todorovic M, Aglietta M, Sangiolo D (2011) "Transient proteasome inhibition as a strategy to enhance lentiviral transduction of hematopoietic CD34(+) cells and T lymphocytes: implications for the use of low viral doses and large-size vectors."

Scagliotti G (2011) "Treatment-by-histology interaction analyses in three phase III trials show superiority of pemetrexed in nonsquamous non-small cell lung cancer."

Boccaccio C, Comoglio P (2011) "Tumor cell-derived Timp-1 is necessary for maintaining metastasis-promoting Met-signaling via inhibition of Adam-10."

Gandolfo S (2011) "Vascular endothelial growth factor genetic polymorphisms and haplotypes in female patients with bisphosphonate-related osteonecrosis of the jaws"

Aglietta M (2011) "Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study."

Boccaccio C, Comoglio PM (2011) "Wild-type p53 controls cell motility and invasion by dual regulation of MET expression."